[
  {
    "ts": null,
    "headline": "Incyte: Multiple Drug Launches Bode Well For Future Growth",
    "summary": "Discover why Incyte's strong growth trajectory and upcoming product launches make it an attractive investment with a $94/share price target. Read more here.",
    "url": "https://finnhub.io/api/news?id=b502046268bbac15fc42c0cd256cebab9d7dec16463ee29ba82c2d8e09936f64",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736587800,
      "headline": "Incyte: Multiple Drug Launches Bode Well For Future Growth",
      "id": 132377701,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1493093304/image_1493093304.jpg?io=getty-c-w1536",
      "related": "INCY",
      "source": "SeekingAlpha",
      "summary": "Discover why Incyte's strong growth trajectory and upcoming product launches make it an attractive investment with a $94/share price target. Read more here.",
      "url": "https://finnhub.io/api/news?id=b502046268bbac15fc42c0cd256cebab9d7dec16463ee29ba82c2d8e09936f64"
    }
  }
]